Journal Article
	
	
				- Furan-based Chalcone Annihilates the Multi-Drug-Resistant Pseudomonas aeruginosa and Protects Zebra Fish Against its Infection
- 
		Santosh Pushpa Ramya Ranjan Nayak , Catharine Basty , Seenivasan Boopathi , Loganathan Sumathi Dhivya , Khaloud Mohammed Alarjani , Mohamed Ragab Abdel Gawwad , Raghda Hager , Muthu Kumaradoss Kathiravan , Jesu Arockiaraj 		
- 
			J. Microbiol. 2024;62(2):75-89.   Published online February 21, 2024		
- 
							DOI: https://doi.org/10.1007/s12275-024-00103-6
					
- 
					
		- 
			473
			View
		
- 
			2
			Download
		
- 
			11
			Web of Science
		
- 
			11
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		The emergence of carbapenem-resistant Pseudomonas aeruginosa, a multi-drug-resistant bacteria, is becoming a serious
public health concern. This bacterium infects immunocompromised patients and has a high fatality rate. Both naturally and
synthetically produced chalcones are known to have a wide array of biological activities. The antibacterial properties of
synthetically produced chalcone were studied against P. aeruginosa. In vitro, study of the compound (chalcone derivative
named DKO1), also known as (2E)-1-(5-methylfuran-2-yl)-3-(4-nitrophenyl) prop-2-en-1-one, had substantial antibacterial
and biofilm disruptive action. DKO1 effectively shielded against P. aeruginosa-induced inflammation, oxidative stress, lipid
peroxidation, and apoptosis in zebrafish larvae. In adult zebrafish, the treatment enhanced the chances of survivability and
reduced the sickness-like behaviors. Gene expression, biochemical analysis, and histopathology studies found that proinflammatory
cytokines (TNF-α, IL-1β, IL-6, iNOS) were down regulated; antioxidant enzymes such as superoxide dismutase
(SOD) and catalase (CAT) levels increased, and histoarchitecture was restored in zebrafish. The data indicate that DKO1 is
an effective antibacterial agent against P. aeruginosa demonstrated both in vitro and in vivo.	
		
- 
			Citations Citations to this article as recorded by    
- Chalcone derivative enhance poultry meat preservation through quorum sensing inhibition against Salmonella (Salmonella enterica serovar Typhi) contamination
 S.P. Ramya Ranjan Nayak, Pratik Pohokar, Anamika Das, L.S. Dhivya, Mukesh Pasupuleti, Ilavenil Soundharrajan, Bader O. Almutairi, Kathiravan Muthu Kumaradoss, Jesu Arockiaraj
 Food Control.2025; 171: 111155.     CrossRef
- Harnessing Cyclic di-GMP Signaling: A Strategic Approach to Combat Bacterial Biofilm-Associated Chronic Infections
 P. Snega Priya, Ramu Meenatchi, Mukesh Pasupuleti, S. Karthick Raja Namasivayam, Jesu Arockiaraj
 Current Microbiology.2025;[Epub]     CrossRef
- Targeted inhibition of PqsR in Pseudomonas aeruginosa PAO1 quorum-sensing network by chalcones as promising antibacterial compounds
 Negin Arami, Amineh Sadat Tajani, Maryam Hashemi, Tahoura Rezaei, Razieh Ghodsi, Vahid Soheili, Bibi Sedigheh Fazly Bazzaz
 Molecular Biology Reports.2025;[Epub]     CrossRef
- Exposure to bisphenol A and sodium nitrate found in processed meat induces endocrine disruption and dyslipidemia through PI3K/AKT/SREBP pathway in zebrafish larvae
 Santosh Pushpa Ramya Ranjan Nayak, Anamika Das, Karthikeyan Ramamurthy, Mukesh Pasupuleti, Rajakrishnan Rajagopal, Jesu Arockiaraj
 The Journal of Nutritional Biochemistry.2025; 140: 109887.     CrossRef
- Starch films with triethanolamine and chalcone derivative for improved durability and antimicrobial properties in poultry packaging
 S.P. Ramya Ranjan Nayak, Pratik Pohokar, L.S. Dhivya, Aveeda Herold, V. Chitra, Mansour K. Gatasheh, Selvaraj Arokiyaraj, Kathiravan Muthu Kumaradoss, Jesu Arockiaraj
 International Journal of Biological Macromolecules.2025; 316: 144627.     CrossRef
- Efficacy of 6-nitrobenzo[d]thiazol-2 Amine Derivative (N3) in Mitigating PTZ-Induced Epileptic Conditions Via Modulation of Inflammatory and Neuroprotective Pathways in-vivo Zebrafish
 Karthikeyan Ramamurthy, S. P. Ramya Ranjan Nayak, S. Madesh, Siva Prasad Panda, K. Manikandan, Rajakrishnan Rajagopal, Ahmed Alfarhan, Senthilkumar Palaniappan, Ajay Guru, M. K. Kathiravan, Jesu Arockiaraj
 Journal of Neuroimmune Pharmacology.2025;[Epub]     CrossRef
- Testing of Anti-EMT, Anti-Inflammatory and Antibacterial Activities of 2′,4′-Dimethoxychalcone
 Peiling Zhao, Mengzhen Xu, Kai Gong, Kaihui Lu, Chen Ruan, Xin Yu, Jiang Zhu, Haixing Guan, Qingjun Zhu
 Pharmaceuticals.2024; 17(5): 653.     CrossRef
- Furan-based chalcone protects β-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing Peroxisome Proliferator-Activated Receptor agonists (PPAR-γ) signaling
 S.P. Ramya Ranjan Nayak, B. Haridevamuthu, Raghul Murugan, L.S. Dhivya, S. Venkatesan, Mikhlid H. Almutairi, Bader O. Almutairi, M.K. Kathiravan, S. Karthick Raja Namasivayam, Jesu Arockiaraj
 Process Biochemistry.2024; 142: 149.     CrossRef
- Protective role of 2-aminothiazole derivative against ethanol-induced teratogenic effects in-vivo zebrafish
 S. Madesh, Gokul Sudhakaran, Karthikeyan Ramamurthy, Avra Sau, Kathiravan Muthu Kumaradoss, Mikhlid H. Almutairi, Bader O. Almutairi, Senthilkumar Palaniappan, Jesu Arockiaraj
 Biochemical Pharmacology.2024; 230: 116601.     CrossRef
- Tissue damage alleviation and mucin inhibition by P5 in a respiratory infection mouse model with multidrug-resistant Acinetobacter baumannii
 Jun Hee Oh, Jonggwan Park, Hee Kyoung Kang, Hee Joo Park, Yoonkyung Park
 Biomedicine & Pharmacotherapy.2024; 181: 117724.     CrossRef
- Toxicity and therapeutic property of dioxopiperidin derivative SKT40 demonstrated in-vivo zebrafish model due to inflammatory bowel disease
 B. Aswinanand, S.P. Ramya Ranjan Nayak, S. Madesh, Suthi Subbarayudu, S. Kaliraj, Rajakrishnan Rajagopal, Ahmed Alfarhan, Muthu Kumaradoss Kathiravan, Jesu Arockiaraj
 Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology.2024; 284: 109990.     CrossRef
 
 Review
	
	
				- Current status and perspectives on vaccine development against dengue virus infection
- 
		Jisang Park , Ju Kim , Yong-Suk Jang 		
- 
			J. Microbiol. 2022;60(3):247-254.   Published online February 14, 2022		
- 
							DOI: https://doi.org/10.1007/s12275-022-1625-y
					
- 
					
		- 
			421
			View
		
- 
			0
			Download
		
- 
			32
			Web of Science
		
- 
			32
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Dengue virus (DENV) consists of four serotypes in the family
Flaviviridae and is a causative agent of dengue fever, dengue
hemorrhagic fever, and dengue shock syndrome. DENV is
transmitted by mosquitoes, Aedes aegypti and A. albopictus,
and is mainly observed in areas where vector mosquitoes live.
The number of dengue cases reported by the World Health
Organization increased more than 8-fold over the last two
decades from 505,430 in 2000 to over 2.4 million in 2010 to
5.2 million in 2019. Although vaccine is the most effective
 method
 against DENV, only one commercialized vaccine exists,
and it cannot be administered to children under 9 years of
age. Currently, many researchers are working to resolve the
various problems hindering the development of effective dengue
vaccines; understanding of the viral antigen configuration
would provide insight into the development of effective
vaccines against DENV infection. In this review, the current
status and perspectives on effective vaccine development for
DENV are examined. In addition, a plausible direction for
effective vaccine development against DENV is suggested.
- 
			Citations Citations to this article as recorded by    
- Stochastic Runge–Kutta for numerical treatment of dengue epidemic model with Brownian uncertainty
 Nabeela Anwar, Iftikhar Ahmad, Hijab Javaid, Adiqa Kausar Kiani, Muhammad Shoaib, Muhammad Asif Zahoor Raja
 Modern Physics Letters B.2025;[Epub]     CrossRef
- Dengue: epidemiology, diagnosis methods, treatment options, and prevention strategies
 Dimple Kothari, Niralee Patel, Ashok Kumar Bishoyi
 Archives of Virology.2025;[Epub]     CrossRef
- Designing of a novel and potential multi-epitope-based vaccine using NS5 protein of dengue virus targeting all serotypes from India: An immunoinformatic approach
 Ruchi Jaiswal, Pramod Kumar Kushawaha
 The Microbe.2025; 7: 100387.     CrossRef
- Análisis de la efectividad del control por insecticida para el dengue: una perspectiva matemática
 Luis Eduardo López Montenegro
 Ciencia en Desarrollo.2025;[Epub]     CrossRef
- Virus-Like Particle-Based Multiserotype Quartet Vaccine of Dengue Envelope Protein Domain III Elicited Potent Anti-Dengue Responses
 Jirayu Boonyakida, Mami Matsuda, Ryosuke Suzuki, Krishna Raja Muthuraman, Enoch Y. Park
 Biomacromolecules.2025; 26(7): 4449.     CrossRef
- Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
 Supaluk Krittanai, Kaewta Rattanapisit, Christine Joy I. Bulaon, Pannamthip Pitaksajjakul, Sujitra Keadsanti, Pongrama Ramasoota, Richard Strasser, Waranyoo Phoolcharoen
 Biotechnology Reports.2024; 42: e00844.     CrossRef
- In silico strategies for predicting therapeutic peptides targeting the capsid protein of the dengue virus
 Neeraj Kumar Dixit, Ajay Kumar
 Journal of Proteins and Proteomics.2024; 15(4): 675.     CrossRef
- Epidemiologic and clinical updates on viral infections in Saudi Arabia
 Noura M. Alshiban, Munirah S. Aleyiydi, Majed S. Nassar, Nada K. Alhumaid, Thamer A. Almangour, Yahya M.K. Tawfik, Laila A. Damiati, Abdulaziz S. Almutairi, Essam A. Tawfik
 Saudi Pharmaceutical Journal.2024; 32(7): 102126.     CrossRef
- “Seven-Plus-One Model”: A Move Toward Dengue Free Community
 Santosh Kumar, Rakhi Mishra, Dharnidhar Singh
 Indian Journal of Community Medicine.2024; 49(2): 249.     CrossRef
- Dengue fever: a decade of burden in Iran
 Zahra Heydarifard, Fatemeh Heydarifard, Fatemeh Sadat Mousavi, Milad Zandi
 Frontiers in Public Health.2024;[Epub]     CrossRef
- All-Atom Perspective of the DENV-3 Methyltransferase Inhibition Mechanism
 Xiao Liu, Kaiwen Pang, Hangfei Wu, Xiaohui Wang, John Z. H. Zhang, Zhaoxi Sun
 The Journal of Physical Chemistry B.2024; 128(50): 12358.     CrossRef
- Using UAV images and deep learning in investigating potential breeding sites of Aedes albopictus
 Keyi Yu, Jianping Wu, Minghao Wang, Yizhou Cai, Minhui Zhu, Shenjun Yao, Yibin Zhou
 Acta Tropica.2024; 255: 107234.     CrossRef
- Dengue
 Gabriela Paz-Bailey, Laura E Adams, Jacqueline Deen, Kathryn B Anderson, Leah C Katzelnick
 The Lancet.2024; 403(10427): 667.     CrossRef
- Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) as a Novel Score in Early Detection of Complicated Dengue Fever
 Zubia Jamil, Samreen Khalid, Hafiz Muhammad Khan, Ikram Waheed, Amna Ehsan, Mohammed Alissa, Khalid Muhammad, Nayla Munawar, Yasir Waheed
 Journal of Multidisciplinary Healthcare.2024; Volume 17: 2321.     CrossRef
- Dengue Virus 2 NS2B Targets MAVS and IKKε to Evade the Antiviral Innate Immune Response
 Ying Nie, Dongqing Deng, Lumin Mou, Qizhou Long, Jinzhi Chen, Jiahong Wu
 Journal of Microbiology and Biotechnology.2023; 33(5): 600.     CrossRef
- Deep learning approach for detection of Dengue fever from the microscopic images of blood smear
 Hilda Mayrose, Niranjana Sampathila, G Muralidhar Bairy, Tushar Nayak, Sushma Belurkar, Kavitha Saravu
 Journal of Physics: Conference Series.2023; 2571(1): 012005.     CrossRef
- Analysis of the correlation between climatic variables and Dengue cases in the city of Alagoinhas/BA
 Marcos Batista Figueredo, Roberto Luiz Souza Monteiro, Alexandre do Nascimento Silva, José Roberto de Araújo Fontoura, Andreia Rita da Silva, Carolina Aparecida Pereira Alves
 Scientific Reports.2023;[Epub]     CrossRef
- Dengue overview: An updated systemic review
 Muhammad Bilal Khan, Zih-Syuan Yang, Chih-Yen Lin, Ming-Cheng Hsu, Aspiro Nayim Urbina, Wanchai Assavalapsakul, Wen-Hung Wang, Yen-Hsu Chen, Sheng-Fan Wang
 Journal of Infection and Public Health.2023; 16(10): 1625.     CrossRef
- Applying a multi-strain dengue model to epidemics data
 Robert G.S. de Araújo, Daniel C.P. Jorge, Rejane C. Dorn, Gustavo Cruz-Pacheco, M. Lourdes M. Esteva, Suani T.R. Pinho
 Mathematical Biosciences.2023; 360: 109013.     CrossRef
- Impact of bound ssRNA length on allostery in the Dengue Virus NS3 helicase
 Fernando Amrein, Carolina Sarto, Leila A Cababie, F Luis Gonzalez Flecha, Sergio B Kaufman, Mehrnoosh Arrar
 Nucleic Acids Research.2023; 51(20): 11213.     CrossRef
- A novel colorimetric biosensor for rapid detection of dengue virus upon acid-induced aggregation of colloidal gold
 Vo Thi Cam Duyen, Vo Van Toi, Truong Van Hoi, Phuoc Long Truong
 Analytical Methods.2023; 15(32): 3991.     CrossRef
- Aromatic Residues on the Side Surface of Cry4Ba-Domain II of Bacillus thuringiensis subsp. israelensis Function in Binding to Their Counterpart Residues on the Aedes aegypti Alkaline Phosphatase Receptor
 Anon Thammasittirong, Sutticha Na-Ranong Thammasittirong
 Toxins.2023; 15(2): 114.     CrossRef
- Recombinant Protein Mimicking the Antigenic Structure of the Viral Surface Envelope Protein Reinforces Induction of an Antigen-Specific and Virus-Neutralizing Immune Response Against Dengue Virus
 Ju Kim, Tae Young Lim, Jisang Park, Yong-Suk Jang
 Journal of Microbiology.2023; 61(1): 131.     CrossRef
- Prevalence of dengue fever in Saudi Arabia: Jeddah as a case study
 Hanan S. Alyahya
 Entomological Research.2023; 53(12): 539.     CrossRef
- Biological Functions and Utilization of Different Part of the Papaya: A Review
 Mingyue Jiao, Chao Liu, M.A. Prieto, Xiaoming Lu, Wenfu Wu, Jinyue Sun, P. García-Oliveira, Xiaozhen Tang, Jianbo Xiao, Jesus Simal-Gandara, Dagang Hu, Ningyang Li
 Food Reviews International.2023; 39(9): 6781.     CrossRef
- Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement
 Li-Chen Yen, Hsin-Wei Chen, Chia-Lo Ho, Chang-Chi Lin, Yi-Ling Lin, Qiao-Wen Yang, Kuo-Chou Chiu, Shu-Pei Lien, Ren-Jye Lin, Ching-Len Liao
 Journal of Biomedical Science.2023;[Epub]     CrossRef
- Dengue hemorrhagic fever: a growing global menace
 Shakeela Parveen, Zainab Riaz, Saba Saeed, Urwah Ishaque, Mehwish Sultana, Zunaira Faiz, Zainab Shafqat, Saman Shabbir, Sana Ashraf, Amna Marium
 Journal of Water and Health.2023; 21(11): 1632.     CrossRef
- Exploring the inhibitory potential of Nigella sativa against dengue virus NS2B/NS3 protease and NS5 polymerase using computational approaches
 Mamuna Mukhtar, Haris Ahmed Khan, Najam us Sahar Sadaf Zaidi
 RSC Advances.2023; 13(27): 18306.     CrossRef
- Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors
 Alexis A. Hatton, Fermin E. Guerra
 Viruses.2022; 15(1): 52.     CrossRef
- Two years of COVID-19 pandemic: where are we now?
 Jinjong Myoung
 Journal of Microbiology.2022; 60(3): 235.     CrossRef
- Predictors of complicated dengue infections in endemic region of Pakistan
 Ikram Waheed, Samreen Khalid, Zubia Jamil
 Asian Pacific Journal of Tropical Medicine.2022; 15(11): 496.     CrossRef
- Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches
 Mamuna Mukhtar, Amtul Wadood Wajeeha, Najam us Sahar Sadaf Zaidi, Naseeha Bibi
 International Journal of Molecular Sciences.2022; 23(22): 13911.     CrossRef
 
 Journal Article
	
	
				- Potent antibacterial and antibiofilm activities of TICbf-14, a peptide with increased stability against trypsin
- 
		Liping Wang , Xiaoyun Liu , Xinyue Ye , Chenyu Zhou , Wenxuan Zhao , Changlin Zhou , Lingman Ma 		
- 
			J. Microbiol. 2022;60(1):89-99.   Published online December 29, 2021		
- 
							DOI: https://doi.org/10.1007/s12275-022-1368-9
					
- 
					
		- 
			280
			View
		
- 
			0
			Download
		
- 
			2
			Web of Science
		
- 
			2
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		The poor stability of peptides against trypsin largely limits
their development as potential antibacterial agents. Here, to
obtain a peptide with increased trypsin stability and potent
antibacterial activity, TICbf-14 derived from the cationic peptide
Cbf-14 was designed by the addition of disulfide-bridged
hendecapeptide (CWTKSIPPKPC) loop. Subsequently, the
trypsin stability and antimicrobial and antibiofilm activities
of this peptide were evaluated. The possible mechanisms underlying
its mode of action were also clarified. The results
showed that TICbf-14 exhibited elevated trypsin inhibitory
activity and effectively mitigated lung histopathological damage
in bacteria-infected mice by reducing the bacterial counts,
further inhibiting the systemic dissemination of bacteria and
host inflammation. Additionally, TICbf-14 significantly repressed
bacterial swimming motility and notably inhibited
biofilm formation. Considering the mode of action, we observed
that TICbf-14 exhibited a potent membrane-disruptive
mechanism, which was attributable to its destructive effect
on ionic bridges between divalent cations and LPS of the bacterial
membrane. Overall, TICbf-14, a bifunctional peptide
with both antimicrobial and trypsin inhibitory activity, is
highly likely to become an ideal candidate for drug development
against bacteria.	
		
- 
			Citations Citations to this article as recorded by    
- Modified polymeric biomaterials with antimicrobial and immunomodulating properties
 Katarzyna Szałapata, Mateusz Pięt, Martyna Kasela, Marcin Grąz, Justyna Kapral-Piotrowska, Aleksandra Mordzińska-Rak, Elżbieta Samorek, Paulina Pieniądz, Jolanta Polak, Monika Osińska-Jaroszuk, Roman Paduch, Bożena Pawlikowska-Pawlęga, Anna Malm, Anna Jar
 Scientific Reports.2024;[Epub]     CrossRef
- Epinecidin-1, a marine antifungal peptide, inhibits Botrytis cinerea and delays gray mold in postharvest peaches
 Li Fan, Yingying Wei, Yi Chen, Shu Jiang, Feng Xu, Chundan Zhang, Hongfei Wang, Xingfeng Shao
 Food Chemistry.2023; 403: 134419.     CrossRef
 
 Reviews
	
	
				- MINIREVIEW] Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development
- 
		Hansong Chae , Sung Jae Shin 		
- 
			J. Microbiol. 2018;56(5):300-311.   Published online May 2, 2018		
- 
							DOI: https://doi.org/10.1007/s12275-018-8041-3
					
- 
					
		- 
			238
			View
		
- 
			0
			Download
		
- 
			22
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Tuberculosis (TB), caused by Mycobacterium tuberculosis
(Mtb), remains a serious global health problem in the 21st
century because of its high mortality. Mtb is an extremely
successful human-adapted pathogen that displays a multifactorial
ability to control the host immune response and to
evade killing by drugs, resulting in the breakdown of BCG
vaccine-conferred anti-TB immunity and development of
multidrug-resistant (MDR) and extensively drug-resistant
(XDR) Mtb. Although genetic components of the genomes
of the Mtb complex strains are highly conserved, showing
over 99% similarity to other bacterial genera, recently accumulated
evidence suggests that the genetic diversity of the
Mtb complex strains has implications for treatment outcomes,
development of MDR/XDR Mtb, BCG vaccine efficacy,
transmissibility, and epidemiological outbreaks. Thus, new
insights into the pathophysiological features of the Mtb complex
strains are required for development of novel vaccines
and for control of MDR/XDR Mtb infection, eventually leading
to refinement of treatment regimens and the health care
system. Many studies have focused on the differential identification
of Mtb complex strains belonging to different lineages
because of differences in their virulence and geographical
dominance. In this review, we discuss the impact of
differing genetic characteristics among Mtb complex strains
on vaccine efficacy, treatment outcome, development of MDR/
XDR Mtb strains, and epidemiological outbreaks by focusing
on the best-adapted human Mtb lineages. We further
explore the rationale for differential identification of Mtb
strains for more effective control of TB in clinical and laboratory
settings by scrutinizing current diagnostic methods.	
		
- 
			Citations Citations to this article as recorded by    
- Comparative growth kinetics and drug susceptibility of Mycobacterium tuberculosis lineages prevalent in Ethiopia: implications for tuberculosis treatment and management
 Tesfaye Gebreyohannis Hailemariam, Melaku Tilahun, Abay Atnafu, Tesfaye Gelanew, Tewodros Tariku Gebresilase, Mekdes Alemu Tola, Abaysew Ayele, Shewki Moga Siraj, Workineh Shibeshi, Kidist Bobosha, Liya Wassie, Yonas Hirutu, Ephrem Engidawork
 Frontiers in Microbiology.2025;[Epub]     CrossRef
- Detection of tuberculous and non-tuberculous mycobacterial species in trans-tracheal washes of cattle and buffaloes with respiratory distress
 Sudhir Kumar Prajapati, Deepti Narang, Mudit Chandra, Ashwani Sharma, Sikh Tejinder Singh
 Tropical Animal Health and Production.2025;[Epub]     CrossRef
- Graphene Oxide‐Assisted Tapered Microfiber Super‐Sensor for Rapid Detection of Mycobacterium tuberculosis Antigens
 Ren Liu, Tianhuan Song, Xiaolin Chen, Zhiheng Yu, Cunliang Yang, Xianchao Zhang, Fengli Huang, Hao Jia, Jijun Feng, Yujiong Wang
 Biotechnology and Bioengineering.2025; 122(4): 1025.     CrossRef
- Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review
 Haiyang Zhang, Yi Liao, Zhensheng Zhu, Hanmin Liu, Deyuan Li, Sisi Wang
 Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
- Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification
 Haiyang Zhang, Maoting Tang, Deyuan Li, Min Xu, Yusen Ao, Liangkang Lin
 Frontiers in Public Health.2024;[Epub]     CrossRef
- Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosis
 Meg L. Donovan, Helle Bielefeldt‐Ohmann, Rachel F. Rollo, Stephen J. McPherson, Thomas E. Schultz, Giorgia Mori, Jessica C. Kling, Antje Blumenthal
 Immunology.2023; 169(1): 13.     CrossRef
- Host vs. pathogen evolutionary arms race: Effects of exposure history on individual response to a genetically diverse pathogen
 Daniel P. Walsh, Brandi L. Felts, E. Frances Cassirer, Thomas E. Besser, Jonathan A. Jenks
 Frontiers in Ecology and Evolution.2023;[Epub]     CrossRef
- Antimycobacterial Activity of Hedeoma drummondii against Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria
 Carmen Molina-Torres, Carlos Pedraza-Rodríguez, Lucio Vera-Cabrera, Jorge Ocampo-Candiani, Catalina Rivas-Morales, Ezequiel Viveros-Valdez
 Antibiotics.2023; 12(5): 833.     CrossRef
- Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
 Anabel Ordaz-Vázquez, Pedro Torres-González, Leticia Ferreyra-Reyes, Sergio Canizales-Quintero, Guadalupe Delgado-Sánchez, Lourdes García-García, Alfredo Ponce-De-León, José Sifuentes-Osornio, Miriam Bobadilla-Del-Valle
 BMC Infectious Diseases.2023;[Epub]     CrossRef
- Will we ever eradicate animal tuberculosis?
 Christian Gortázar, José de la Fuente, Alberto Perelló, Lucas Domínguez
 Irish Veterinary Journal.2023;[Epub]     CrossRef
- Predominance of the Mycobacterium tuberculosis Beijing strain amongst children from a high tuberculosis burden township in South Africa
 Junaid Shaik, Manormoney Pillay, Julie Moodley, Prakash Jeena
 Tuberculosis.2022; 136: 102250.     CrossRef
- Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima—Peru
 Kattya Lopez, María B. Arriaga, Juan G. Aliaga, Nadia N. Barreda, Oswaldo M. Sanabria, Chuan-Chin Huang, Zibiao Zhang, Ruth García-de-la-Guarda, Leonid Lecca, Anna Cristina Calçada Carvalho, Afrânio L. Kritski, Roger I. Calderon, Igor Mokrousov
 PLOS ONE.2021; 16(1): e0243184.     CrossRef
- In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients
 Ruoyan Ying, Xiaochen Huang, Yaxian Gao, Jie Wang, Yidian Liu, Wei Sha, Hua Yang
 Infection and Drug Resistance.2021; Volume 14: 3729.     CrossRef
- Characterisation of secretome-based immune responses of human leukocytes infected with variousMycobacterium tuberculosislineages
 Benjawan Kaewseekhao, Sittiruk Roytrakul, Yodying Yingchutrakul, Marut Laohaviroj, Kanin Salao, Kiatichai Faksri
 PeerJ.2021; 9: e11565.     CrossRef
- Different PPD-stimulated cytokine responses from patients infected with genetically distinct Mycobacterium tuberculosis complex lineages
 Paulo Ranaivomanana, Marie Sylvianne Rabodoarivelo, Mame Diarra Bousso Ndiaye, Niaina Rakotosamimanana, Voahangy Rasolofo
 International Journal of Infectious Diseases.2021; 104: 725.     CrossRef
- A review of published spoligotype data indicates the diversity of Mycobacterium tuberculosis from India is under-represented in global databases
 Husain Poonawala, Narender Kumar, Sharon J. Peacock
 Infection, Genetics and Evolution.2020; 78: 104072.     CrossRef
- Comparing IS6110‐RFLP, PGRS‐RFLP and IS6110‐Mtb1/Mtb2 PCR methods for genotyping ofMycobacterium tuberculosisisolates
 Kh. Ansarin, L. Sahebi, Y. Aftabi, M. Khalili, M. Seyyedi
 Journal of Applied Microbiology.2020; 129(4): 1062.     CrossRef
- Molecular Typing of Mycobacterium Tuberculosis Isolated from Iranian Patients Using Highly Abundant Polymorphic GC-Rich-Repetitive Sequence
 Bahram Golestani Eimani, Khalil Ansarin, Leila Sahebi, Maryam Seyyedi
 Iranian South Medical Journal.2020; 23(2): 87.     CrossRef
- Comparison of the Three Molecular Diagnostic Assays for Molecular Identification ofMycobacterium tuberculosisand Nontuberculous Mycobacteria Species in Sputum Samples
 Jinyoung Bae, Sung-Bae Park, Ji-Hoi Kim, Mi Ran Kang, Kyung Eun Lee, Sunghyun Kim, Hyunwoo Jin
 Biomedical Science Letters.2020; 26(3): 170.     CrossRef
- Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent Mycobacterium tuberculosis Beijing K Strain
 Woo Sik Kim, Hongmin Kim, Kee Woong Kwon, Sang-Nae Cho, Sung Jae Shin
 Frontiers in Microbiology.2019;[Epub]     CrossRef
- Molecular characterisation of multidrug-resistantMycobacterium tuberculosisisolates from a high-burden tuberculosis state in Brazil
 R. S. Salvato, S. Schiefelbein, R. B. Barcellos, B. M. Praetzel, I. S. Anusca, L. S. Esteves, M. L. Halon, G. Unis, C.F. Dias, S. S. Miranda, I. N. de Almeida, L. J. de Assis Figueredo, E. C. Silva, A. L. Kritski, E. R. Dalla Costa, M. L. R. Rossetti
 Epidemiology and Infection.2019;[Epub]     CrossRef
- DNA markers for tuberculosis diagnosis
 Kai Ling Chin, Maria E. Sarmiento, Mohd Nor Norazmi, Armando Acosta
 Tuberculosis.2018; 113: 139.     CrossRef
 
 
	
	
				- MINIREVIEW] Cure of tuberculosis using nanotechnology: An overview
- 
		Rout George Kerry , Sushanto Gouda , Bikram Sil , Gitishree Das , Han-Seung Shin , Gajanan Ghodake , Jayanta Kumar Patra 		
- 
			J. Microbiol. 2018;56(5):287-299.   Published online May 2, 2018		
- 
							DOI: https://doi.org/10.1007/s12275-018-7414-y
					
- 
					
		- 
			242
			View
		
- 
			0
			Download
		
- 
			9
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Mycobacterium tuberculosis is the causative agent of tuberculosis
(TB), a major health issue of the present era. The bacterium
inhabits the host macrophage and other immune cells
where it modulates the lysosome trafficking protein, hinders
the formation of phagolysosome, and blocks the TNF receptor-
dependent apoptosis of host macrophage/monocytes.
Other limitations such as resistance to and low bioavailability
and bio-distribution of conventional drugs aid to their high
virulence and human mortality. This review highlights the
use of nanotechnology-based approaches for drug formulation
and delivery which could open new avenues to limit the
pathogenicity of tuberculosis. Moreover phytochemicals, such
as alkaloids, phenols, saponins, steroids, tannins, and terpenoids,
extracted from terrestrial plants and mangroves seem
promising against M. tuberculosis through different molecular
mechanisms. Further understanding of the genomics
and proteomics of this pathogenic microbe could also help
overcome various research gaps in the path of developing a
suitable therapy against tuberculosis.	
		
- 
			Citations Citations to this article as recorded by    
 Journal Articles
	
	
				- Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
- 
		Ji-Chan Jang , Yong-Gyun Jung , Jungil Choi , Hyunju Jung , Sungweon Ryoo 		
- 
			J. Microbiol. 2017;55(6):483-487.   Published online April 20, 2017		
- 
							DOI: https://doi.org/10.1007/s12275-017-6630-1
					
- 
					
		- 
			252
			View
		
- 
			0
			Download
		
- 
			6
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		This study aimed to provide information that bedaquilline is significantly effective for treatment of totally drug resistant (TDR) Mycobacterium tuberculosis that shows resistant to all first- and second-line drugs-using an innovative disc agarose channel (DAC) system. Time-lapse images of single bacterial cells under culture conditions with different concentrations of bedaquiline were analysed by image processing software to determine minimum inhibitory concentrations (MICs). Bedaquiline inhibited the growth of TDR M. tuberculosis strains, with MIC values ranging from 0.125 to 0.5 mg/L. The results of the present study demonstrate that bedaquiline, newly approved by the United States Food and Drug Admi-nistration (FDA), may offer therapeutic solutions for TDR -TB.	
		
- 
			Citations Citations to this article as recorded by    
- Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
 Rong Yao, Bin Wang, Lei Fu, Lei Li, Kejun You, Yong-Guo Li, Yu Lu, Luiz Pedro Sorio de Carvalho
 Microbiology Spectrum.2022;[Epub]     CrossRef
- Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis
 Nitin Verma, Vimal Arora, Rajendra Awasthi, Yinghan Chan, Niraj Kumar Jha, Komal Thapa, Talha Jawaid, Mehnaz Kamal, Gaurav Gupta, Gang Liu, Keshav Raj Paudel, Philip Michael Hansbro, Brian Gregory George Oliver, Sachin Kumar Singh, Dinesh Kumar Chellappan
 Journal of Drug Delivery Science and Technology.2022; 75: 103690.     CrossRef
- 
            In vitro activity of bedaquiline against Mycobacterium avium complex
 Vitaly Litvinov, Marina Makarova, Dmitry Kudlay, Nikolai Nikolenko, Julia Mikhailova
 Journal of Medical Microbiology
.2021;[Epub]     CrossRef
- Problems of drug resistance of M. tuberculosis
 V. I. Litvinov, E. Yu. Nosova
 Tuberculosis and socially significant diseases.2021; 9(2): 70.     CrossRef
- Bedaquiline and linezolid MIC distributions and epidemiological cut-off values forMycobacterium tuberculosisin the Latin American region
 Beatriz Lopez, Rosangela Siqueira de Oliveira, Juliana M W Pinhata, Erica Chimara, Edson Pacheco Ascencio, Zully M Puyén Guerra, Ingrid Wainmayer, Norberto Simboli, Mirtha Del Granado, Juan Carlos Palomino, Viviana Ritacco, Anandi Martin
 Journal of Antimicrobial Chemotherapy.2019; 74(2): 373.     CrossRef
- Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon
 Zubair Shanib Bhat, Muzafar Ahmad Rather, Mubashir Maqbool, Zahoor Ahmad
 Biomedicine & Pharmacotherapy.2018; 103: 1733.     CrossRef
 
 
	
	
				- Performance of nested multiplex PCR assay targeting MTP40 and IS6110 gene sequences for the diagnosis of tubercular lymphadenitis
- 
		Pallavi Sinha , Pradyot Prakash , Shashikant C.U. Patne , Shampa Anupurba , Sweety Gupta , G. N. Srivastava 		
- 
			J. Microbiol. 2017;55(1):63-67.   Published online December 30, 2016		
- 
							DOI: https://doi.org/10.1007/s12275-017-6127-y
					
- 
					
		- 
			258
			View
		
- 
			0
			Download
		
- 
			5
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		The conventional methods for diagnosis of tubercular lymphadenitis
(TBLN) such as - fine needle aspiration cytology,
Ziehl-Neelsen staining and culture have limitations of low
sensitivity and/or specificity. So, it becomes essential to develop
a rapid, sensitive, and specific method for an early diagnosis
of TBLN. Therefore, the present study was conducted
to evaluate nested multiplex polymerase chain reaction
(nMPCR) targeting MTP40 and IS6110 gene sequences
of Mycobacterium tuberculosis and Mycobacterium
tuberculosis complex, respectively in 48 successive patients
of TBLN and 20 random patients with non-tubercular lymph
node lesions. Out of the 48 cases of TBLN, 14 (29.2%) were
found to be positive by Ziehl-Neelsen staining, 15 (31.2%)
were positive by culture and 43 (89.6%) cases were positive
after first round of PCR while 48 (100%) cases were positive
by nMPCR assay. The sensitivity and specificity of nMPCR
was found to be 100% for the diagnosis of TBLN. The results
thus obtained indicate that nMPCR assay is a highly sensitive
and specific tool for the diagnosis of TBLN.	
		
- 
			Citations Citations to this article as recorded by    
- Diagnosis of tuberculous lymphadenitis by molecular and immunological tools
 Nitin Kumar, Anish Khan, Sanjit Boora, Neha Chadha, Nisha Khan, Puneet Raina, Rajesh Gupta, Raj Singh, Samander Kaushik
 Medicine in Microecology.2024; 22: 100116.     CrossRef
- Evaluating the Sensitivity of Different Molecular Techniques for Detecting Mycobacterium tuberculosis Complex in Patients with Pulmonary Infection
 Hassan A. Hemeg, Hamzah O. Albulushi, Hani A. Ozbak, Hamza M. Ali, Emad K. Alahmadi, Yahya A. Almutawif, Sari T. Alhuofie, Rana A. Alaeq, Areej A. Alhazmi, Mustafa A. Najim, Ahmed M. Hanafy
 Polish Journal of Microbiology.2023; 72(4): 421.     CrossRef
- The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa
 Prince Asare, Adwoa Asante-Poku, Stephen Osei-Wusu, Isaac Darko Otchere, Dorothy Yeboah-Manu
 Frontiers in Public Health.2021;[Epub]     CrossRef
- Two target genes based multiple cross displacement amplification combined with a lateral flow biosensor for the detection of Mycobacterium tuberculosis complex
 Junfei Huang, Ziyu Xiao, Xinggui Yang, Xu Chen, Xiaojuan Wang, Yijiang Chen, Wenlin Zheng, Wei Chen, Huijuan Chen, Shijun Li
 BMC Microbiology.2021;[Epub]     CrossRef
- Duplex PCR for Detection of Aleutian Disease Virus from Biological and Environmental Samples
 Marek Kowalczyk, Andrzej Jakubczak, Magdalena Gryzińska
 Acta Veterinaria.2019; 69(4): 402.     CrossRef
 
 
	
	
				- The assessment of host and bacterial proteins in sputum from active pulmonary tuberculosis
- 
		Hsin-Chih Lai , Yu-Tze Horng , Pen-Fang Yeh , Jann-Yuan Wang , Chin-Chung Shu , Jang-Jih Lu , Jen-Jyh Lee , Po-Chi Soo 		
- 
			J. Microbiol. 2016;54(11):761-767.   Published online October 29, 2016		
- 
							DOI: https://doi.org/10.1007/s12275-016-6201-x
					
- 
					
		- 
			238
			View
		
- 
			0
			Download
		
- 
			2
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Pulmonary tuberculosis (TB) is caused by Mycobacterium
tuberculosis. The protein composition of sputum may reflect
the immune status of the lung. This study aimed to evaluate
the protein profiles in spontaneous sputum samples from
patients with active pulmonary TB. Sputum samples were
collected from patients with pulmonary TB and healthy controls.
Western blotting was used to analyze the amount of interleukin
10 (IL-10), interferon-gamma (IFN-γ), IL-25, IL-
17, perforin-1, urease, albumin, transferrin, lactoferrin, adenosine
deaminase (also known as adenosine aminohydrolase,
or ADA), ADA-2, granzyme B, granulysin, and caspase-
1 in sputum. Results of detection of IL-10, IFN-γ, perforin-
1, urease, ADA2, and caspase-1, showed relatively high
specificity in distinguishing patients with TB from healthy
controls, although sensitivities varied from 13.3% to 66.1%.
By defining a positive result as the detection of any two proteins
in sputum samples, combined use of transferrin and
urease as markers increased sensitivity to 73.2% and specificity
to 71.1%. Furthermore, we observed that the concentration of transferrin was proportional to the number of acidfast
bacilli detected in sputum specimens. Detection of sputum
transferrin and urease was highly associated with pulmonary
TB infection. In addition, a high concentration of
transferrin detected in sputum might correlate with active
TB infection. This data on sputum proteins in patients with
TB may aid in the development of biomarkers to assess the
severity of pulmonary TB.	
		
- 
			Citations Citations to this article as recorded by    
- From simple to complex: Protein‐based biomarker discovery in tuberculosis
 Zaynab Mousavian, Gunilla Källenius, Christopher Sundling
 European Journal of Immunology.2023;[Epub]     CrossRef
- Interleukin 8 and Pentaxin (C-Reactive Protein) as Potential New Biomarkers of Bovine Tuberculosis
 Xintao Gao, Xiaoyu Guo, Ming Li, Hong Jia, Weidong Lin, Lichun Fang, Yitong Jiang, Hongfei Zhu, Zhifang Zhang, Jiabo Ding, Ting Xin, Brad Fenwick
 Journal of Clinical Microbiology.2019;[Epub]     CrossRef
 
 
	
	
				- Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation
- 
		Elisabetta Iona , Manuela Pardini , Alessandro Mustazzolu , Giovanni Piccaro , Roberto Nisini , Lanfranco Fattorini , Federico Giannoni 		
- 
			J. Microbiol. 2016;54(8):565-572.   Published online August 2, 2016		
- 
							DOI: https://doi.org/10.1007/s12275-016-6150-4
					
- 
					
		- 
			335
			View
		
- 
			0
			Download
		
- 
			41
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		The physiology of dormant Mycobacterium tuberculosis was
studied in detail by examining the gene expression of 51
genes using quantitative Reverse-Transcription Polymerase
Chain Reaction. A forty-day period of dormancy in the Wayne
culture model depicted four major transcription patterns.
Some sigma factors and many metabolic genes were constant,
whereas genes belonging to the dormancy regulon were activated
on day 9. In particular, alpha-crystallin mRNA showed
more than a 1,000-fold increase compared to replicating bacilli.
Genes belonging to the enduring hypoxic response were
up-regulated at day 16, notably, transcription factors sigma
B and E. Early genes typical of log-phase bacilli, esat-6 and
fbpB, were uniformly down-regulated during dormancy. Late
stages of dormancy showed a drop in gene expression likely
due to a lack of substrates in anaerobic respiration as demonstrated
by the transcriptional activation observed following
nitrates addition. Among genes involved in nitrate metabolism,
narG was strongly up-regulated by nitrates addition.
Dormant bacilli responded very rapidly when exposed
to oxygen and fresh medium, showing a transcriptional activation
of many genes, including resuscitation-promoting
factors, within one hour. Our observations extend the current
knowledge on dormant M. tuberculosis gene expression
and its response to nutrients and to aerobic and anaerobic
respiration.	
		
- 
			Citations Citations to this article as recorded by    
- Expression of Resuscitation‐Promoting Factor C Stimulates the Growth of Mycobacterium bovis BCG and Delays DevR Regulon Activation in Hypoxia
 Luz Virginia Reyes-González, Olga N. Hernández de la Cruz, Mauricio Castañón-Arreola, Saeed Mohammadi
 International Journal of Microbiology.2025;[Epub]     CrossRef
- Macrophage Differentiation and Metabolic Adaptation in Mycobacterial Infections
 Anne Kathrin Lösslein, Philipp Henneke
 Annual Review of Immunology
.2025; 43(1): 423.     CrossRef
- Biochemistry of Reactivation of Dormant Mycobacteria
 Margarita O. Shleeva, Galina R. Demina, Arseny S. Kaprelyants
 Biochemistry (Moscow).2025; 90(S1): S193.     CrossRef
- Regulatory role of Mycobacterium tuberculosis MtrA on dormancy/resuscitation revealed by a novel target gene-mining strategy
 Xiang Fu, Xiaoyu Wan, Aadil Ahmed Memon, Xiao-Yong Fan, Qiuhong Sun, Haifeng Chen, Yufeng Yao, Zixin Deng, Jian Ma, Wei Ma
 Frontiers in Microbiology.2024;[Epub]     CrossRef
- Adaptation of the Mycobacterium tuberculosis transcriptome to biofilm growth
 Madison A. Youngblom, Tracy M. Smith, Holly J. Murray, Caitlin S. Pepperell, Christopher M. Sassetti
 PLOS Pathogens.2024; 20(4): e1012124.     CrossRef
- Identification of Rv1133c (MetE) as a marker of Mycobacterium tuberculosis replication and as a highly immunogenic antigen with potential immunodiagnostic power
 Angelo Iacobino, Raffaela Teloni, Carmine Mancone, Francesco Facchiano, Alessandra Di Giamberardino, Cinzia Senatore, Antonio Di Virgilio, Alessio Lanni, Federico Giannoni, Roberto Nisini, Sabrina Mariotti
 Frontiers in Immunology.2024;[Epub]     CrossRef
- Advances in understanding immune homeostasis in latent tuberculosis infection
 Liangfei Niu, Hao Wang, Geyang Luo, Jing Zhou, Zhidong Hu, Bo Yan
 WIREs Mechanisms of Disease.2024;[Epub]     CrossRef
- Microneedle patch-based enzyme-linked immunosorbent assay to quantify protein biomarkers of tuberculosis
 Youngeun Kim, Mary Beth Lewis, Jihyun Hwang, Zheyu Wang, Rohit Gupta, Yuxiong Liu, Tuhina Gupta, James P. Barber, Srikanth Singamaneni, Fred Quinn, Mark R. Prausnitz
 Biomedical Microdevices.2024;[Epub]     CrossRef
- Mycobacterium tuberculosis Adaptation in Response to Isoniazid Treatment in a Multi-Stress System That Mimics the Host Environment
 Manita Yimcharoen, Sukanya Saikaew, Usanee Wattananandkul, Ponrut Phunpae, Sorasak Intorasoot, Chatchai Tayapiwatana, Bordin Butr-Indr
 Antibiotics.2023; 12(5): 852.     CrossRef
- Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
 Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, Federico Giannoni
 Microorganisms.2023; 11(6): 1511.     CrossRef
- Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
 Sam Afkhami, Michael R. D’Agostino, Maryam Vaseghi-Shanjani, Madeleine Lepard, Jack X. Yang, Rocky Lai, Margaret Wa Yan Choi, Alexis Chacon, Anna Zganiacz, Kees L. M. C. Franken, Hildegund C. Ertl, Tom H. M. Ottenhoff, Mangalakumari Jeyanathan, Amy Gillgr
 npj Vaccines.2023;[Epub]     CrossRef
- WhiB4 Is Required for the Reactivation of Persistent Infection of Mycobacterium marinum in Zebrafish
 Chen Lin, Yuting Tang, Yuchen Wang, Junli Zhang, Yeyu Li, Shuqin Xu, Bin Xia, Qiran Zhai, Yao Li, Lu Zhang, Jun Liu, Amit Singh
 Microbiology Spectrum.2022;[Epub]     CrossRef
- Mycobacterium tuberculosis whiB3 and Lipid Metabolism Genes Are Regulated by Host Induced Oxidative Stress
 Omar M. Barrientos, Elizabeth Langley, Yolanda González, Carlos Cabello, Martha Torres, Silvia Guzmán-Beltrán
 Microorganisms.2022; 10(9): 1821.     CrossRef
- Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays
 V. Dirix, N. Dauby, M. Hites, E. Watelet, A. Van Praet, A. Godefroid, E. Petit, M. Singh, C. Locht, F. Mascart, V. Corbière, Christine Y. Turenne
 Journal of Clinical Microbiology.2022;[Epub]     CrossRef
- Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
 Akanksha Verma, Antara Ghoshal, Ved Prakash Dwivedi, Ashima Bhaskar
 Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
- Mycobacterial PPE36 Modulates Host Inflammation by Promoting E3 Ligase Smurf1-Mediated MyD88 Degradation
 Zhangli Peng, Yan Yue, Sidong Xiong
 Frontiers in Immunology.2022;[Epub]     CrossRef
- Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country
 Violette Dirix, Philippe Collart, Anne Van Praet, Maya Hites, Nicolas Dauby, Sabine Allard, Judith Racapé, Mahavir Singh, Camille Locht, Françoise Mascart, Véronique Corbière
 Frontiers in Immunology.2022;[Epub]     CrossRef
- The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment
 Manita Yimcharoen, Sukanya Saikaew, Usanee Wattananandkul, Ponrut Phunpae, Sorasak Intorasoot, Watchara Kasinrerk, Chatchai Tayapiwatana, Bordin Butr-Indr
 Infection and Drug Resistance.2022; Volume 15: 399.     CrossRef
- Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing M. tuberculosis?
 RJH Hammond, Frank Kloprogge, O. Della Pasqua, Stephen H. Gillespie
 Frontiers in Antibiotics.2022;[Epub]     CrossRef
- Strain-Specific Behavior of Mycobacterium tuberculosis  in Interruption of Autophagy Pathway in  Human Alveolar Type II Epithelial A549 Cells
 Nasim Ebrahimifard, Shima Hadifar, Mansour Kargarpour Kamakoli, Ava Behrouzi, Sharareh Khanipour, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
 Iranian Biomedical Journal.2022; 26(4): 313.     CrossRef
- Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger
 Elena G. Salina, Vadim Makarov
 Microorganisms.2022; 10(12): 2334.     CrossRef
- Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium tuberculosis
 Manikuntala Kundu, Joyoti Basu
 Frontiers in Microbiology.2021;[Epub]     CrossRef
- Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis
 M.A. Abo-Kadoum, Yongdong Dai, Mohammed Asaad, Insaf Hamdi, Jianping Xie
 Microbial Drug Resistance.2021; 27(6): 768.     CrossRef
- Insights into the evolutionary history of the virulent factor HBHA of Mycobacterium tuberculosis
 Mariana P. Lanfranconi, Ana Arabolaza, Hugo Gramajo, Héctor M. Alvarez
 Archives of Microbiology.2021; 203(5): 2171.     CrossRef
- Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care
 Darius Riziki Martin, Nicole Remaliah Sibuyi, Phumuzile Dube, Adewale Oluwaseun Fadaka, Ruben Cloete, Martin Onani, Abram Madimabe Madiehe, Mervin Meyer
 Diagnostics.2021; 11(8): 1352.     CrossRef
- Transcriptome Changes of Mycobacterium marinum in the Process of Resuscitation From Hypoxia-Induced Dormancy
 Jun Jiang, Chen Lin, Junli Zhang, Yuchen Wang, Lifang Shen, Kunpeng Yang, Wenxuan Xiao, Yao Li, Lu Zhang, Jun Liu
 Frontiers in Genetics.2020;[Epub]     CrossRef
- Immunoinformatics Approach to Engineer a Potent Poly-epitope Fusion Protein Vaccine Against Coxiella burnetii
 Ehsan Rashidian, Zeinab Shakarami Gandabeh, Ali Forouharmehr, Narges Nazifi, Nemat Shams, Amin Jaydari
 International Journal of Peptide Research and Therapeutics.2020; 26(4): 2191.     CrossRef
- Coordinate regulation of virulence and metabolic genes by the transcription factor HbhR in Mycobacterium marinum
 Dominique Raze, Jérôme Segers, Céline Mille, Stéphanie Slupek, Sophie Lecher, Loïc Coutte, Rudy Antoine, Lucie Ducrocq, Carine Rouanet, Ben J. Appelmelk, Camille Locht
 Molecular Microbiology.2020; 113(1): 52.     CrossRef
- Small RNA Mcr11 requires the transcription factor AbmR for stable expression and regulates genes involved in the central metabolism of Mycobacterium tuberculosis
 Roxie C. Girardin, Kathleen A. McDonough
 Molecular Microbiology.2020; 113(2): 504.     CrossRef
- Resuscitation of Dormant “Non-culturable” Mycobacterium tuberculosis Is Characterized by Immediate Transcriptional Burst
 Elena G. Salina, Artem S. Grigorov, Oksana S. Bychenko, Yulia V. Skvortsova, Ilgar Z. Mamedov, Tatyana L. Azhikina, Arseny S. Kaprelyants
 Frontiers in Cellular and Infection Microbiology.2019;[Epub]     CrossRef
- Defining the Transcriptional and Post-transcriptional Landscapes of Mycobacterium smegmatis in Aerobic Growth and Hypoxia
 M. Carla Martini, Ying Zhou, Huaming Sun, Scarlet S. Shell
 Frontiers in Microbiology.2019;[Epub]     CrossRef
- Immunoscreening of the M. tuberculosis F15/LAM4/KZN secretome library against TB patients′ sera identifies unique active- and latent-TB specific biomarkers
 Thamsanqa E. Chiliza, Manormoney Pillay, Kogieleum Naidoo, Balakrishna Pillay
 Tuberculosis.2019; 115: 161.     CrossRef
- Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures
 Yana R. Batyrshina, Yakov Sh Schwartz
 Tuberculosis.2019; 117: 7.     CrossRef
- The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH
 Angelo Iacobino, Federico Giannoni, Manuela Pardini, Giovanni Piccaro, Lanfranco Fattorini
 Antimicrobial Agents and Chemotherapy.2019;[Epub]     CrossRef
- Bacteriophage gene products as potential antimicrobials against tuberculosis
 Maria Puiu, Christina Julius
 Biochemical Society Transactions.2019; 47(3): 847.     CrossRef
- The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection
 Musa Marimani, Aijaz Ahmad, Adriano Duse
 Tuberculosis.2018; 113: 200.     CrossRef
- Host-pathogen redox dynamics modulate Mycobacterium tuberculosis pathogenesis
 Hayden T Pacl, Vineel P Reddy, Vikram Saini, Krishna C Chinta, Adrie J C Steyn
 Pathogens and Disease.2018;[Epub]     CrossRef
- Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria
 Dominique Raze, Claudie Verwaerde, Gaspard Deloison, Elisabeth Werkmeister, Baptiste Coupin, Marc Loyens, Priscille Brodin, Carine Rouanet, Camille Locht
 Frontiers in Microbiology.2018;[Epub]     CrossRef
- Opening Pandora’s Box: Mechanisms of Mycobacterium tuberculosis Resuscitation
 Ashley V. Veatch, Deepak Kaushal
 Trends in Microbiology.2018; 26(2): 145.     CrossRef
- AbmR (Rv1265) is a novel transcription factor of Mycobacterium tuberculosis that regulates host cell association and expression of the non‐coding small RNA Mcr11
 Roxie C. Girardin, Guangchun Bai, Jie He, Haixin Sui, Kathleen A. McDonough
 Molecular Microbiology.2018; 110(5): 811.     CrossRef
- Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptation
 Florence Levillain, Yannick Poquet, Ludovic Mallet, Serge Mazères, Michael Marceau, Roland Brosch, Franz-Christoph Bange, Philip Supply, Axel Magalon, Olivier Neyrolles, Marcel A. Behr
 PLOS Pathogens.2017; 13(11): e1006752.     CrossRef
 
 Research Support, Non-U.S. Gov't
	
	
				- A small hairpin RNA targeting myeloid cell leukemia-1 enhances apoptosis in host macrophages infected with Mycobacterium tuberculosis
- 
		Fei-yu Wang , Yu-qing Zhang , Xin-min Wang , Chan Wang , Xiao-fang Wang , Jiang-dong Wu , Fang Wu , Wan-jiang Zhang , Le Zhang 		
- 
			J. Microbiol. 2016;54(4):330-337.   Published online April 1, 2016		
- 
							DOI: https://doi.org/10.1007/s12275-016-5627-5
					
- 
					
		- 
			277
			View
		
- 
			0
			Download
		
- 
			5
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Myeloid cell leukemia-1 (Mcl-1) plays an important role in
various cell survival pathways. Some studies indicated that
the expression of Mcl-1 was upregulated in host cells during
infection with the virulent Mycobacterium tuberculosis strain,
H37Rv. The present study was designed to investigate the
effect of inhibiting Mcl-1 expression both in vivo and in vitro
on apoptosis of host macrophages infected with M. tuberculosis
using a small hairpin (sh)RNA. Mcl-1 expression was detected
by the real time-polymerase chain reaction, western blotting,
and immunohistochemistry. Flow cytometry and transmission
electron microscopy were used to measure host macrophage
apoptosis. We found elevated Mcl-1 levels in host macrophages
infected with M. tuberculosis H37Rv. The expression of Mcl-1
was downregulated efficiently in H37Rv-infected host macrophages
using shRNA. Knockdown of Mcl-1 enhanced the
extent of apoptosis in H37Rv-infected host macrophages
significantly. The increased apoptosis correlated with a decrease
in M. tuberculosis colony forming units recovered from
H37Rv-infected cells that were treated with Mcl-1-shRNA.
Reducing Mcl-1 accumulation by shRNA also reduced accumulation
of the anti-apoptotic gene, Bcl-2, and increased
expression of the pro-apoptotic gene, Bax, in H37Rv-infected
host macrophages. Our results showed that specific knockdown
of Mcl-1 expression increased apoptosis of host macrophages
significantly and decreased the intracellular survival
of a virulent strain of M. tuberculosis. These data indicate that interference with Mcl-1 expression may provide
a new avenue for tuberculosis therapy.	
		
- 
			Citations Citations to this article as recorded by    
- Tolerance of Listeria monocytogenes to biocides used in food processing environments
 Sanelisiwe Thinasonke Duze, Musa Marimani, Mrudula Patel
 Food Microbiology.2021; 97: 103758.     CrossRef
- Regulatory role and mechanism of the inhibition of the Mcl-1 pathway during apoptosis and polarization of H37Rv-infected macrophages
 Ling Han, Yang Lu, Xiaofang Wang, Shujun Zhang, Yingzi Wang, Fang Wu, Wanjiang Zhang, Xinmin Wang, Le Zhang
 Medicine.2020; 99(42): e22438.     CrossRef
- Current and emerging therapies to combat persistent intracellular pathogens
 Philip Arandjelovic, Marcel Doerflinger, Marc Pellegrini
 Current Opinion in Pharmacology.2019; 48: 33.     CrossRef
- PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis
 Eusondia Arnett, Ashlee M. Weaver, Kiersten C. Woodyard, Maria J. Montoya, Michael Li, Ky V. Hoang, Andrew Hayhurst, Abul K. Azad, Larry S. Schlesinger, Thomas R. Hawn
 PLOS Pathogens.2018; 14(6): e1007100.     CrossRef
- Effect of gap junctions on RAW264.7 macrophages infected with H37Rv
 Yang Lu, Xin-min Wang, Pu Yang, Ling Han, Ying-zi Wang, Zhi-hong Zheng, Fang Wu, Wan-jiang Zhang, Le Zhang
 Medicine.2018; 97(35): e12125.     CrossRef
 
 Research Support, N.I.H., Extramural
	
	
				- The Mycobacterium tuberculosis relBE toxin:antitoxin genes are stress-responsive modules that regulate growth through translation inhibition
- 
		Shaleen B. Korch , Vandana Malhotra , Heidi Contreras , Josephine E. Clark-Curtiss 		
- 
			J. Microbiol. 2015;53(11):783-795.   Published online October 28, 2015		
- 
							DOI: https://doi.org/10.1007/s12275-015-5333-8
					
- 
					
		- 
			293
			View
		
- 
			0
			Download
		
- 
			45
			Crossref
		
		- 
						
						 Abstract Abstract
- 
		Toxin-antitoxin (TA) genes are ubiquitous among bacteria
and are associated with persistence and dormancy. Following
exposure to unfavorable environmental stimuli, several species
(Escherichia coli, Staphylococcus aureus, Myxococcus
xanthus) employ toxin proteins such as RelE and MazF to
downregulate growth or initiate cell death. Mycobacterium
tuberculosis possesses three Rel TA modules (RelMtb): RelBEMtb,
RelFGMtb and RelJKMtb (Rv1246c-Rv1247c, Rv2865-Rv2866,
and Rv3357-Rv3358, respectively), which inhibit mycobacterial
growth when the toxin gene (relE, relG, relK) is expressed
independently of the antitoxin gene (relB, relF, relJ).
In the present study, we examined the in vivo mechanism of
the RelEMtb toxin protein, the impact of RelEMtb on M. tuberculosis
physiology and the environmental conditions that regulate
all three relMtb modules. RelEMtb negatively impacts
growth and the structural integrity of the mycobacterial envelope,
generating cells with aberrant forms that are prone
to extensive aggregation. At a time coincident with growth
defects, RelEMtb mediates mRNA degradation in vivo resulting
in significant changes to the proteome. We establish that
relMtb modules are stress responsive, as all three operons are
transcriptionally activated following mycobacterial exposure
to oxidative stress or nitrogen-limiting growth environments.
Here we present evidence that the relMtb toxin:antitoxin family
is stress-responsive and, through the degradation of mRNA,
the RelEMtb toxin influences the growth, proteome and morphology
of mycobacterial cells.	
		
- 
			Citations Citations to this article as recorded by    
- Genome wide screening to discover novel toxin–antitoxin modules in Mycobacterium indicus pranii; perspective on gene acquisition during mycobacterial evolution
 Aayush Bahl, Roopshali Rakshit, Saurabh Pandey, Deeksha Tripathi
 Biotechnology and Applied Biochemistry.2025; 72(1): 116.     CrossRef
- Investigation of potential relationship betweenmazEF3, relJK, and vapBC3 genes and antimicrobial resistance inMycobacterium bovis
 Maryam Shafipour, Abdolmajid Mohammadzadeh, Ezzat Allah Ghaemi, Pezhman Mahmoodi, Nader Mosavari
 BMC Infectious Diseases.2025;[Epub]     CrossRef
- Insight into the environmental cues modulating the expression of bacterial toxin–antitoxin systems
 Emeline Ostyn, Yoann Augagneur, Marie-Laure Pinel-Marie
 FEMS Microbiology Reviews.2025;[Epub]     CrossRef
- Mono- and multidomain defense toxins of the RelE/ParE superfamily
 Kenn Gerdes, Michael T. Laub
 mBio.2025;[Epub]     CrossRef
- 
            Ser/Thr phosphorylation of
            Mycobacterium tuberculosis
            type II RelK toxin by PknK destabilizes TA interaction and interferes with toxin neutralization
          
 Shafinaz Rahman Sarah, Abhishek Garg, Sadiyah Afroz, Shaleen Korch, Arjun Ray, Amita Gupta, Vandana Malhotra, Tarek Msadek, Promod K. Mehta
 mBio.2025;[Epub]     CrossRef
- The identification Mycobacterium tuberculosis genes that modulate long term survival in the presence of rifampicin and streptomycin
 Johana E. Hernández Toloza, Ye Xu, Tom A. Mendum, Bianca Sica Siedler, Rosalyn Casey, Huihai Wu, Kerstin Williams, Suzanne Hingley-Wilson, Johnjoe McFadden
 Scientific Reports.2025;[Epub]     CrossRef
- Resilience to stress and antibiotics, coupled with immunomodulatory behavior, uncovers Mycobacterium indicus pranii as a suitable surrogate model for tuberculosis research
 Aayush Bahl, Khushboo Negi, Anupam Anupam, Simran Choudhary, Sashi Kant, Saurabh Pandey, Deeksha Tripathi
 Biochemical and Biophysical Research Communications.2025; 777: 152296.     CrossRef
- Bacterial persisters: molecular mechanisms and therapeutic development
 Hongxia Niu, Jiaying Gu, Ying Zhang
 Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
- Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
 Yiduo Liu, Han Li, Dejia Dai, Jiakang He, Zhengmin Liang
 Current Issues in Molecular Biology.2024; 46(6): 5825.     CrossRef
- Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants
 Zian Zhang, Lifa Xu, Xiaochun Wang, LingYun Kong, Zilun Shi, Qiangsen Zhong, Yun Xu, Jianghong Wang
 Tuberculosis.2024; 145: 102480.     CrossRef
- Enhancement of mycobacterial pathogenesis by host interferon-γ
 Huynh Tan Hop, Pao-Chi Liao, Hsin-Yi Wu
 Cellular and Molecular Life Sciences.2024;[Epub]     CrossRef
- Distribution of lineages and type II toxin-antitoxin systems among rifampin-resistant Mycobacterium Tuberculosis Isolates
 Maryam Shafipour, Abdolmajid Mohammadzadeh, Pezhman Mahmoodi, Mahdi Dehghanpour, Ezzat Allah Ghaemi, Francesca Boldrin
 PLOS ONE.2024; 19(10): e0309292.     CrossRef
- The zoonotic pathogen Wohlfahrtiimonas chitiniclastica – current findings from a clinical and genomic perspective
 Anna Kopf, Boyke Bunk, Thomas Riedel, Percy Schröttner
 BMC Microbiology.2024;[Epub]     CrossRef
- PCR Development for Analysis of Some Type II Toxin–Antitoxin Systems, relJK, mazEF3, and vapBC3 Genes, in Mycobacterium tuberculosis and Mycobacterium bovis
 Maryam Shafipour, Abdolmajid Mohammadzadeh, Ezzat Allah Ghaemi, Pezhman Mahmoodi
 Current Microbiology.2024;[Epub]     CrossRef
- Multitargeting: An Alternative Approach to Tackle Multidrug Resistance
in Tuberculosis
 Satakshi Hazra, Risha Hazarika, Sanjukta Patra
 Current Drug Targets.2023; 24(9): 751.     CrossRef
- Salidroside Attenuates Cisplatin-Induced Ototoxicity: An Experimental Study In Vitro and In Vivo
 Kanglun Jiang, Tan Wang, Zirui Zhao, Lei Zhou, Huaili Jiang, Na Shen, Daquan Wu, Xinsheng Huang
 Journal of Biomedical Nanotechnology.2023; 19(4): 600.     CrossRef
- The past, present and future of tuberculosis treatment
 Kefan BI, Dan CAO, Cheng DING, Shuihua LU, Hongzhou LU, Guangyu ZHANG, Wenhong ZHANG, Liang LI, Kaijin XU, Lanjuan LI, Ying ZHANG
 Journal of Zhejiang University (Medical Sciences).2022; 51(6): 657.     CrossRef
- Cellular functions of the ClpP protease impacting bacterial virulence
 Mazen E. Aljghami, Marim M. Barghash, Emily Majaesic, Vaibhav Bhandari, Walid A. Houry
 Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
- Comparative Genomic Analysis of the Human Pathogen Wohlfahrtiimonas Chitiniclastica Provides Insight Into the Identification of Antimicrobial Resistance Genotypes and Potential Virulence Traits
 Anna Kopf, Boyke Bunk, Sina M. Coldewey, Florian Gunzer, Thomas Riedel, Percy Schröttner
 Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
- Mycobacterium tuberculosis PknK Substrate Profiling Reveals Essential Transcription Terminator Protein Rho and Two-Component Response Regulators PrrA and MtrA as Novel Targets for Phosphorylation
 Vandana Malhotra, Blessing P. Okon, Akash T. Satsangi, Sumana Das, Uchenna Watson Waturuocha, Atul Vashist, Josephine E. Clark-Curtiss, Deepak Kumar Saini, Amit Singh
 Microbiology Spectrum.2022;[Epub]     CrossRef
- Transcriptional profiling of the stringent response mutant strain E. coli SR reveals enhanced robustness to large‐scale conditions
 Martin Ziegler, Julia Zieringer, Ralf Takors
 Microbial Biotechnology.2021; 14(3): 993.     CrossRef
- Persistence of Intracellular Bacterial Pathogens—With a Focus on the Metabolic Perspective
 Wolfgang Eisenreich, Thomas Rudel, Jürgen Heesemann, Werner Goebel
 Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
- Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
 Laura Veschetti, Angela Sandri, Cristina Patuzzo, Paola Melotti, Giovanni Malerba, Maria M. Lleò
 Microorganisms.2021; 9(1): 130.     CrossRef
- Genome‐wide interaction screen for Mycobacterium tuberculosis ClpCP protease reveals toxin–antitoxin systems as a major substrate class
 Michal Ziemski, Julia Leodolter, Gabrielle Taylor, Anne Kerschenmeyer, Eilika Weber‐Ban
 The FEBS Journal.2021; 288(1): 99.     CrossRef
- Evaluating the Potential for Cross-Interactions of Antitoxins in Type II TA Systems
 Chih-Han Tu, Michelle Holt, Shengfeng Ruan, Christina Bourne
 Toxins.2020; 12(6): 422.     CrossRef
- Targeting Type II Toxin–Antitoxin Systems as Antibacterial Strategies
 Marcin Równicki, Robert Lasek, Joanna Trylska, Dariusz Bartosik
 Toxins.2020; 12(9): 568.     CrossRef
- Persister cell development among Enterobacteriaceae, Pseudomonadaceae, Mycobacteriaceae and Staphylococcaceae biotypes: A review
 Somanath Behera, Smaranika Pattnaik
 Biocatalysis and Agricultural Biotechnology.2019; 22: 101401.     CrossRef
- Toxins targeting transfer RNAs: Translation inhibition by bacterial toxin–antitoxin systems
 Lauren R. Walling, J. Scott Butler
 WIREs RNA.2019;[Epub]     CrossRef
- The relevance of persisters in tuberculosis drug discovery
 Soma Mandal, Samuel Njikan, Anuradha Kumar, Julie V. Early, Tanya Parish
 Microbiology
.2019; 165(5): 492.     CrossRef
- The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection
 Dongzhu Ma, Jonathan B. Mandell, Niles P. Donegan, Ambrose L. Cheung, Wanyan Ma, Scott Rothenberger, Robert M. Q. Shanks, Anthony R. Richardson, Kenneth L. Urish, Jon P. Boyle
 mBio.2019;[Epub]     CrossRef
- Toxin–antitoxin systems shows variability among Mycobacterium tuberculosis lineages
 J S Solano-Gutierrez, C Pino, J Robledo
 FEMS Microbiology Letters.2019;[Epub]     CrossRef
- Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people
 Wing W. Yew, Takashi Yoshiyama, Chi C. Leung, Denise P. Chan
 Respirology.2018; 23(6): 567.     CrossRef
- RE: “DIETARY INTAKE OF ANTIOXIDANT VITAMINS AND CAROTENOIDS AND RISK OF DEVELOPING ACTIVE TUBERCULOSIS IN A PROSPECTIVE POPULATION-BASED COHORT”
 Wing Wai Yew, Denise P Chan, Chi Chiu Leung, Ying Zhang
 American Journal of Epidemiology.2018; 187(7): 1570.     CrossRef
- System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis
 Sakshi Agarwal, Prabhakar Tiwari, Amar Deep, Saqib Kidwai, Shamba Gupta, Krishan Gopal Thakur, Ramandeep Singh
 The Journal of Infectious Diseases.2018; 217(11): 1809.     CrossRef
- Does oxidative stress contribute to adverse outcomes in HIV-associated TB?
 Wing-Wai Yew, Denise P Chan, Amit Singhal, Ying Zhang, Shui-Shan Lee
 Journal of Antimicrobial Chemotherapy.2018; 73(5): 1117.     CrossRef
- Co-expression network analysis of toxin-antitoxin loci in Mycobacterium tuberculosis reveals key modulators of cellular stress
 Amita Gupta, Balaji Venkataraman, Madavan Vasudevan, Kiran Gopinath Bankar
 Scientific Reports.2017;[Epub]     CrossRef
- The endobacterium of an arbuscular mycorrhizal fungus modulates the expression of its toxin–antitoxin systems during the life cycle of its host
 Alessandra Salvioli di Fossalunga, Justine Lipuma, Francesco Venice, Laurence Dupont, Paola Bonfante
 The ISME Journal.2017; 11(10): 2394.     CrossRef
- Oxidative stress and TB outcomes in patients with diabetes mellitus?
 Wing Wai Yew, Chi Chiu Leung, Ying Zhang
 Journal of Antimicrobial Chemotherapy.2017; 72(6): 1552.     CrossRef
- Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016
 Arundhati Maitra, Tengku Karmila Kamil, Monisha Shaik, Cynthia Amaning Danquah, Alina Chrzastek, Sanjib Bhakta
 Virulence.2017; 8(6): 1005.     CrossRef
- Identification of four type II toxin-antitoxin systems in Actinobacillus pleuropneumoniae
 Chengkun Zheng, Xigong Zhao, Ting Zeng, Manman Cao, Jiali Xu, Guolin Shi, Jinquan Li, Huanchun Chen, Weicheng Bei
 FEMS Microbiology Letters.2017;[Epub]     CrossRef
- Emerging drugs and drug targets against tuberculosis
 Nzungize Lambert, Abualgasim Elgaili Abdalla, Xiangke Duan, Jianping Xie
 Journal of Drug Targeting.2017; 25(4): 296.     CrossRef
- Wake me when it’s over – Bacterial toxin–antitoxin proteins and induced dormancy
 Nathan P Coussens, Dayle A Daines
 Experimental Biology and Medicine.2016; 241(12): 1332.     CrossRef
- Emerging Roles of Toxin-Antitoxin Modules in Bacterial Pathogenesis
 Barbara Kędzierska, Finbarr Hayes
 Molecules.2016; 21(6): 790.     CrossRef
- 
            Phenotypic Heterogeneity in
            Mycobacterium tuberculosis
          
 Neeraj Dhar, John McKinney, Giulia Manina, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
 Microbiology Spectrum.2016;[Epub]     CrossRef
- tRNAs taking charge
 Jonathan W. Cruz, Nancy A. Woychik, Peter Sebo
 Pathogens and Disease.2016; 74(2): ftv117.     CrossRef
 
 Research Support, Non-U.S. Gov'ts
	
	
				- Performance of a real-time PCR assay for the rapid identification of Mycobacterium species
- 
		Hye-young Wang , Hyunjung Kim , Sunghyun Kim , Do-kyoon Kim , Sang-Nae Cho , Hyeyoung Lee 		
- 
			J. Microbiol. 2015;53(1):38-46.   Published online January 4, 2015		
- 
							DOI: https://doi.org/10.1007/s12275-015-4495-8
					
- 
					
		- 
			292
			View
		
- 
			0
			Download
		
- 
			20
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Mycobacteria cause a variety of illnesses that differ in severity
and public health implications. The differentiation of
Mycobacterium tuberculosis (MTB) from nontuberculous
mycobacteria (NTM) is of primary importance for infection
control and choice of antimicrobial therapy. The diagnosis
of diseases caused by NTM is difficult because NTM species
are prevalent in the environment and because they have fastidious
properties. In the present study, we evaluated 279
clinical isolates grown in liquid culture provided by The
Catholic University of Korea, St. Vincent’s Hospital using
real-time PCR based on mycobacterial rpoB gene sequences.
The positive rate of real-time PCR assay accurately discriminated
100% (195/195) and 100% (84/84) between MTB and
NTM species. Comparison of isolates identified using the
MolecuTech REBA Myco-ID? and Real Myco-ID? were completely
concordant except for two samples. Two cases that
were identified as mixed infection (M. intracellulare-M. massiliense
and M. avium-M. massiliense co-infection) by PCRREBA
assay were only detected using M. abscessus-specific
probes by Real Myco-ID?. Among a total of 84 cases, the
most frequently identified NTM species were M. intracellulare
(n=38, 45.2%), M. avium (n=18, 23.7%), M. massiliense
(n=10, 13.2%), M. fortuitum (n=5, 6%), M. abscessus
(n=3, 3.9%), M. gordonae (n=3, 3.9%), M. kansasii (n=2,
2.4%), M. mucogenicum (n=2, 2.4%), and M. chelonae (n=
1, 1.2%). Real Myco-ID? is an efficient tool for the rapid detection
of NTM species as well as MTB and sensitive and
specific and comparable to conventional methods.	
		
- 
			Citations Citations to this article as recorded by    
- 
            Durlobactam to boost the clinical utility of standard of care β-lactams against
            Mycobacterium abscessus
            lung disease
          
 Dereje A. Negatu, Wassihun Wedajo Aragaw, Tewodros T. Gebresilase, Sindhuja Paruchuri, Firat Kaya, Sung Jae Shin, Peter Sander, Véronique Dartois, Thomas Dick, Jared A. Silverman
 Antimicrobial Agents and Chemotherapy.2025;[Epub]     CrossRef
- 
            Application of engineered CRISPR/Cas12a variants with altered protospacer adjacent motif specificities for the detection of isoniazid resistance mutations in
            Mycobacterium tuberculosis
          
 Peng Liu, Jinping Zhang, Yaqi Gong, Wenqi Liu, Guohui Xiao, Juan Liang, Xuan Wang, Jing Bi, Guoliang Zhang, Bindu Singh
 Microbiology Spectrum.2025;[Epub]     CrossRef
- Rapid identification of major Mycobacterium species by loop-mediated isothermal amplification assay using novel species-specific genomic targets
 Yuanwu Zou, Zhuo Wang, Zihan Wei, Guanghong Bai, Xiaolin Wang, Shaoyi Qu, Guowei Zhong, Yanbin Gao
 Frontiers in Cellular and Infection Microbiology.2025;[Epub]     CrossRef
- Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens
 Guocan Yu, Yanqin Shen, Liwei Yao, Xudong Xu
 Infection and Drug Resistance.2024; Volume 17: 673.     CrossRef
- Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations
 Véronique Dartois, Tracey L. Bonfield, Jim P. Boyce, Charles L. Daley, Thomas Dick, Mercedes Gonzalez-Juarrero, Shashank Gupta, Igor Kramnik, Gyanu Lamichhane, Barbara E. Laughon, Nicola I. Lorè, Kenneth C. Malcolm, Kenneth N. Olivier, Katherine L. Tuggle
 Tuberculosis.2024; 147: 102503.     CrossRef
- Epidemiology and laboratory detection of non-tuberculous mycobacteria
 Nuo Xu, Lihong Li, Shenghai Wu
 Heliyon.2024; 10(15): e35311.     CrossRef
- Molecular identification of non-tuberculous mycobacterial species isolated from extrapulmonary samples using real-time PCR and rpoB sequence analysis
 Mohammad Hashemzadeh, Aram Asarehzadegan Dezfuli, Azar Dokht Khosravi, Maryam Moradi Bandbal, Atousa Ghorbani, Mahtab Hamed, Soolmaz Khandan Dezfuli
 AMB Express.2023;[Epub]     CrossRef
- TO ANALYZE THE TB-PCR POSITIVITY RATE USING REAL-TIME PCR FOR EARLY DETECTION OF TUBERCULOSIS
 DEEPAK SAWANT, LOKHANDE CD, SHARMA RK, CHOUGULE RA
 Asian Journal of Pharmaceutical and Clinical Research.2023; : 167.     CrossRef
- Factors Associated with the Performance of Direct PCR Detection of Mycobacteria in Clinical Specimens: Retrospective Real-world Data
 Chang-Hun Park
 Laboratory Medicine Online.2023; 13(3): 205.     CrossRef
- Evaluation of a new assay for nontuberculous mycobacteria species identification in diagnostic material and cultures
 Tatiana Smirnova, Vera Ustinova, Sofya Andreevskaya, Elena Larionova, Ekaterina Kiseleva, Larisa Chernousova, Dmitry Varlamov, Dmitry Sochivko, Atadzhan Ergeshov
 Tuberculosis.2021; 130: 102124.     CrossRef
- 
            Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major
            Mycobacterium
            Species
          
 Guohui Xiao, Xing He, Su Zhang, Yaya Liu, Zhihang Liang, Houming Liu, Juanjuan Zhang, Min Ou, Shuhao Cai, Wenjie Lai, Tianyu Zhang, Lili Ren, Guoliang Zhang, Yi-Wei Tang
 Journal of Clinical Microbiology.2020;[Epub]     CrossRef
- Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens
 Sunghwan Shin, In Young Yoo, Hyang Jin Shim, On Kyun Kang, Byung Woo Jhun, Won-Jung Koh, Hee Jae Huh, Nam Yong Lee
 Annals of Laboratory Medicine.2020; 40(2): 169.     CrossRef
- Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates
 Ellappan Kalaiarasan, Kalpana Thangavelu, Krishnakumariamma Krishnapriya, Muthaiah Muthuraj, Maria Jose, Noyal Mariya Joseph
 Tuberculosis.2020; 125: 101988.     CrossRef
- Comparison of the Three Molecular Diagnostic Assays for Molecular Identification ofMycobacterium tuberculosisand Nontuberculous Mycobacteria Species in Sputum Samples
 Jinyoung Bae, Sung-Bae Park, Ji-Hoi Kim, Mi Ran Kang, Kyung Eun Lee, Sunghyun Kim, Hyunwoo Jin
 Biomedical Science Letters.2020; 26(3): 170.     CrossRef
- 
            Rapid Identification of Clinically Relevant
            Mycobacterium
            Species by Multicolor Melting Curve Analysis
          
 Ye Xu, Bin Liang, Chen Du, Xueshan Tian, Xingshan Cai, Yanjie Hou, Hui Li, Rongrong Zheng, Junlian Li, Yuqin Liu, Kaili Wang, Muhammad Ammar Athar, Yaoju Tan, Qingge Li, Melissa B. Miller
 Journal of Clinical Microbiology.2019;[Epub]     CrossRef
- Mycobacterium abscessus Complex Cutaneous Infection
 Ruben Porudominsky, Eduardo H. Gotuzzo
 Current Tropical Medicine Reports.2018; 5(3): 170.     CrossRef
- The assessment of host and bacterial proteins in sputum from active pulmonary tuberculosis
 Hsin-Chih Lai, Yu-Tze Horng, Pen-Fang Yeh, Jann-Yuan Wang, Chin-Chung Shu, Chia-Chen Lu, Jang-Jih Lu, Jen-Jyh Lee, Po-Chi Soo
 Journal of Microbiology.2016; 54(11): 761.     CrossRef
- Efectos adversos de terapia inmunosupresora en paciente reumatológico: infección por micobacterias no tuberculosas
 Jean Sebastian Hurtado Hurtado
 Reumatología Clínica.2016; 12(2): 118.     CrossRef
- Adverse Effects of Immunosuppressive Therapy in Rheumatic Patients: Non-tuberculous Mycobacterial Infection
 Jean Sebastian Hurtado Hurtado
 Reumatología Clínica (English Edition).2016; 12(2): 118.     CrossRef
- Nontuberculous Mycobacterial Lung Disease Caused byMycobacterium shinjukuense: The First Reported Case in Korea
 Seong Mi Moon, Su-Young Kim, Myung Jin Chung, Seung Heon Lee, Sung Jae Shin, Won-Jung Koh
 Tuberculosis and Respiratory Diseases.2015; 78(4): 416.     CrossRef
 
 
	
	
				- Phosphorylation Regulates Mycobacterial Proteasome
- 
		Tripti Anandan , Jaeil Han , Heather Baun , Seeta Nyayapathy , Jacob T. Brown , Rebekah L. Dial , Juan A. Moltalvo , Min-Seon Kim , Seung Hwan Yang , Donald R. Ronning , Robert N. Husson , Joowon Suh , Choong-Min Kang 		
- 
			J. Microbiol. 2014;52(9):743-754.   Published online September 2, 2014		
- 
							DOI: https://doi.org/10.1007/s12275-014-4416-2
					
- 
					
		- 
			241
			View
		
- 
			0
			Download
		
- 
			15
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Mycobacterium tuberculosis possesses a proteasome system that is required for the microbe to resist elimination by the host immune system. Despite the importance of the proteasome in the pathogenesis of tuberculosis, the molecular mechanisms by which proteasome activity is controlled remain largely unknown. Here, we demonstrate that the α-subunit (PrcA) of the M. tuberculosis proteasome is phosphorylated by the PknB kinase at three threonine residues (T84, T202, and T178) in a sequential manner. Furthermore, the proteasome with phosphorylated PrcA enhances the degradation of Ino1, a known proteasomal substrate, suggesting that PknB regulates the proteolytic activity of the proteasome. Previous studies showed that depletion of the proteasome and the proteasome- associated proteins decreases resistance to reactive nitrogen intermediates (RNIs) but increases resistance to hydrogen peroxide (H2O2). Here we show that PknA phosphorylation of unprocessed proteasome β-subunit (pre-PrcB) and α-subunit reduces the assembly of the proteasome complex and thereby enhances the mycobacterial resistance to H2O2 and that H2O2 stress diminishes the formation of the proteasome complex in a PknA-dependent manner. These findings indicate that phosphorylation of the M. tuberculosis proteasome not only modulates proteolytic activity of the proteasome, but also affects the proteasome complex formation contributing to the survival of M. tuberculosis under oxidative stress conditions.	
		
- 
			Citations Citations to this article as recorded by    
- Phosphoproteome modulation by nucleoside diphosphate kinase affects photosynthesis & stress tolerance of Nostoc PCC 7120
 Anurag Kirti, Hema Rajaram
 Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2025; 1873(1): 141054.     CrossRef
- “Pupdates” on proteasomal degradation in bacteria
 Shoshanna C. Kahne, K. Heran Darwin, Julie A. Maupin-Furlow
 Journal of Bacteriology.2025;[Epub]     CrossRef
- Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
 Yiduo Liu, Han Li, Dejia Dai, Jiakang He, Zhengmin Liang
 Current Issues in Molecular Biology.2024; 46(6): 5825.     CrossRef
- 
            Comprehensive essentiality analysis of the
            Mycobacterium kansasii
            genome by saturation transposon mutagenesis and deep sequencing
          
 Keith Levendosky, Niklas Janisch, Luis E. N. Quadri, Sabine Ehrt
 mBio.2023;[Epub]     CrossRef
- Nitrate-nitrite fate and oxygen sensing in dormant Mycobacterium tuberculosis: A bioinorganic approach highlighting the importance of transition metals
 Eduardo H.S. Sousa, Marta S.P. Carepo, José J.G. Moura
 Coordination Chemistry Reviews.2020; 423: 213476.     CrossRef
- 
            The
            Mycobacterium tuberculosis
            Pup-proteasome system regulates nitrate metabolism through an essential protein quality control pathway
          
 Samuel H. Becker, Jordan B. Jastrab, Avantika Dhabaria, Catherine T. Chaton, Jeffrey S. Rush, Konstantin V. Korotkov, Beatrix Ueberheide, K. Heran Darwin
 Proceedings of the National Academy of Sciences.2019; 116(8): 3202.     CrossRef
- PknG supports mycobacterial adaptation in acidic environment
 Ruchi Paroha, Rashmi Chourasia, Rajesh Mondal, Shivendra K. Chaurasiya
 Molecular and Cellular Biochemistry.2018; 443(1-2): 69.     CrossRef
- Bacterial Proteasomes: Mechanistic and Functional Insights
 Samuel H. Becker, K. Heran Darwin
 Microbiology and Molecular Biology Reviews.2017;[Epub]     CrossRef
- How to control an intracellular proteolytic system: Coordinated regulatory switches in the mycobacterial Pup-proteasome system
 Eyal Gur, Maayan Korman, Nir Hecht, Ofir Regev, Shai Schlussel, Nimrod Silberberg, Yifat Elharar
 Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2017; 1864(12): 2253.     CrossRef
- 
            Epigenetic Phosphorylation Control of
            Mycobacterium tuberculosis
            Infection and Persistence
          
 Melissa Richard-Greenblatt, Yossef Av-Gay, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
 Microbiology Spectrum.2017;[Epub]     CrossRef
- Prokaryotic Ubiquitin-Like Protein and Its Ligase/Deligase Enyzmes
 Cyrille L. Delley, Andreas U. Müller, Michal Ziemski, Eilika Weber-Ban
 Journal of Molecular Biology.2017; 429(22): 3486.     CrossRef
- Phosphorylation Modulates Catalytic Activity of Mycobacterial Sirtuins
 Ghanshyam S. Yadav, Sandeep K. Ravala, Neha Malhotra, Pradip K. Chakraborti
 Frontiers in Microbiology.2016;[Epub]     CrossRef
- Pupylation-dependent and -independent proteasomal degradation in mycobacteria
 Frank Imkamp, Michal Ziemski, Eilika Weber-Ban
 Biomolecular Concepts.2015; 6(4): 285.     CrossRef
- Age-related changes in the proteostasis network in the brain of the naked mole-rat: Implications promoting healthy longevity
 Judy C. Triplett, Antonella Tramutola, Aaron Swomley, Jessime Kirk, Kelly Grimes, Kaitilyn Lewis, Miranda Orr, Karl Rodriguez, Jian Cai, Jon B. Klein, Marzia Perluigi, Rochelle Buffenstein, D. Allan Butterfield
 Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2015; 1852(10): 2213.     CrossRef
- Bacterial Proteasome Activator Bpa (Rv3780) Is a Novel Ring-Shaped Interactor of the Mycobacterial Proteasome
 Cyrille L. Delley, Juerg Laederach, Michal Ziemski, Marcel Bolten, Daniel Boehringer, Eilika Weber-Ban, Riccardo Manganelli
 PLoS ONE.2014; 9(12): e114348.     CrossRef
 
 
	
	
				- Characterization of a Novel Antigen of Mycobacterium tuberculosis K Strain and Its Use in Immunodiagnosis of Tuberculosis
- 
		Paul J. Park , Ah Reum Kim , Yangkyo P. Salch , Taeksun Song , Sung Jae Shin , Seung Jung Han , Sang-Nae Cho 		
- 
			J. Microbiol. 2014;52(10):871-878.   Published online August 27, 2014		
- 
							DOI: https://doi.org/10.1007/s12275-014-4235-5
					
- 
					
		- 
			259
			View
		
- 
			0
			Download
		
- 
			7
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		*For correspondence. (S.J. Han) E-mail: hansjung@yuhs.ac / (S.N. Cho)
E-mail: raycho@yuhs.ac
Paul J. Park, Ah Reum Kim, Yangkyo P. Salch,
Taeksun Song, Sung Jae Shin, Seung Jung Han*,
and Sang-Nae Cho*
Department of Microbiology and Institute for Immunology and
Immunological Diseases, Brain Korea 21 Plus Project for the Medical
Sciences, Yonsei University College of Medicine, Seoul 120-752,
Republic of Korea
(Received Apr 16, 2014 / Revised Jul 14, 2014 / Accepted Jul 16, 2014)
Journal of Microbiology (2014) Vol. 52, No. 10, pp. 871–878
Copyright 2014, The Microbiological Society of Korea
DOI 10.1007/s12275-014-4235-5
Characterization of a Novel Antigen of Mycobacterium tuberculosis K
strain and Its Use in Immunodiagnosis of Tuberculosis
Mycobacterium tuberculosis-specific antigens would be of
great value in developing immunodiagnostic tests for tuberculosis
(TB), but regional differences in molecular types of
the organism may result in antigenic variation, which in turn
affects the outcome of the tests. For example, the Beijing
strains of M. tuberculosis are prevalent in East Asia, and in
particular, the K strain and related strains of the Beijing
family, are most frequently isolated during school outbreaks
of TB in South Korea. From comparison of genome sequences
between M. tuberculosis K strain and the H37Rv strain, a
non-Beijing type, we identified a K strain-specific gene, InsB,
which has substantial homology with the ESAT-6-like proteins.
This study was, therefore, initiated to characterize the
InsB protein for its immunogenicity in mice and to confirm
its expression in TB patients by detecting antibodies to the
protein. The InsB gene was cloned from M. tuberculosis K
strain and expressed in Escherichia coli. The recombinant
InsB protein was used for immunization of mice. All mice
showed strong antibody responses to the InsB protein, and
splenocytes stimulated with InsB showed strong IFN-γ and
IL-17 responses and a weak IL-2 response, all of which have
been implicated in disease expression and used for the immunodiagnosis
of TB. Serum samples from TB patients also
showed significant antibody responses to the InsB protein as
compared to healthy control samples. These results indicate
that the InsB protein is an M. tuberculosis K-strain-specific
antigen that could further improve the current immunodiagnostic
 methods
 , especially for the South Korean population.
- 
			Citations Citations to this article as recorded by    
- Association between Mycobacterium tuberculosis genotype and diabetes mellitus/hypertension: a molecular study
 Shengqiong Guo, Shiguang Lei, Prasit Palittapongarnpim, Edward McNeil, Angkana Chaiprasert, Jinlan Li, Huijuan Chen, Weizheng Ou, Komwit Surachat, Wan Qin, Siyu Zhang, Rujuan Luo, Virasakdi Chongsuvivatwong
 BMC Infectious Diseases.2022;[Epub]     CrossRef
- Gradient association between pulmonary tuberculosis and diabetes mellitus among households with a tuberculosis case: a contact tracing-based study
 Shengqiong Guo, Shiguang Lei, Jinlan Li, Ling Li, Huijuan Chen, Virasakdi Chongsuvivatwong
 Scientific Reports.2022;[Epub]     CrossRef
- Diagnostic Potential of a PPE Protein Derived fromMycobacterium tuberculosisBeijing/K Strain
 Ahreum Kim, Kwang Joo Park, Young Sun Kim, Sang-Nae Cho, Hazel M Dockrell, Yun-Gyoung Hur
 Yonsei Medical Journal.2020; 61(9): 789.     CrossRef
- Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent Mycobacterium tuberculosis Beijing K Strain
 Woo Sik Kim, Hongmin Kim, Kee Woong Kwon, Sang-Nae Cho, Sung Jae Shin
 Frontiers in Microbiology.2019;[Epub]     CrossRef
- Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice
 Ahreum Kim, Yun-Gyoung Hur, Sunwha Gu, Sang-Nae Cho, Helene F. Rosenberg
 Clinical and Vaccine Immunology.2017;[Epub]     CrossRef
- Host immune responses to antigens derived from a predominant strain of Mycobacterium tuberculosis
 Yun-Gyoung Hur, Wou Young Chung, Ahreum Kim, Young Sun Kim, Hyon-Suk Kim, Sun-Hee Jang, Yeun Kim, Hyeyoung Lee, Kwang Joo Park, Sang-Nae Cho
 Journal of Infection.2016; 73(1): 54.     CrossRef
- Purification and characterization of a novel glycoprotein from Streptomyces sp. ZX01
 Guoqiang Zhang, Lirong Han, Guifeng Zhang, Xing Zhang, Juntao Feng
 International Journal of Biological Macromolecules.2015; 78: 195.     CrossRef
 
 
	
	
				- Detection of Inhibitors of Phenotypically Drug-tolerant Mycobacterium tuberculosis Using an In Vitro Bactericidal Screen
- 
		Ian M. Bassett , Shichun Lun , William R. Bishai , Haidan Guo , Joanna R. Kirman , Mudassar Altaf , Ronan F. O’Toole 		
- 
			J. Microbiol. 2013;51(5):651-658.   Published online June 25, 2013		
- 
							DOI: https://doi.org/10.1007/s12275-013-3099-4
					
- 
					
		- 
			235
			View
		
- 
			0
			Download
		
- 
			10
			Crossref
		
		- 
						
						 Abstract Abstract PDF PDF
- 
		Many whole cell screens of chemical libraries currently in use are based on inhibition of bacterial growth. The goal of this study was to develop a chemical library screening model that enabled detection of compounds that are active against drug-tolerant non-growing cultures of Mycobacterium tuberculosis. An in vitro model of low metabolically active mycobacteria was established with 8 and 30 day old cultures of M. smegmatis and M. tuberculosis, respectively. Reduction of resazurin was used as a measure of viability and the assay was applied in screens of chemical libraries for bactericidal compounds. The model provided cells that were phenotypically-resilient to killing by first and second-line clinical drugs including rifampicin. Screening against chemical libraries identified proteasome inhibitors, NSC310551 and NSC321206, and a structurally-related series of thiosemicarbazones, as having potent killing activity towards aged cultures. The inhibitors were confirmed as active against virulent M. tuberculosis strains including multi- and extensively-drug resistant clinical isolates. Our library screen enabled detection of compounds with a potent level of bactericidal activity towards phenotypically drug-tolerant cultures of M. tuberculosis.	
		
- 
			Citations Citations to this article as recorded by    
- Cytotoxicity and activity of thiosemicarbazones and semicarbazones in Mycobacterium tuberculosis: a systematic review
 Ana Paula Desiree de Oliveira, Eloísa Gibin Sampiron, Jean Eduardo Meneguello, Andressa Lorena Ieque, Katiany Rizzieri Caleffi Ferracioli, Rosilene Fressatti Cardoso, Fábio Vandresen, Regiane Bertin de Lima Scodro
 Cuadernos de Educación y Desarrollo.2024; 16(6): e4683.     CrossRef
- High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery
 Navid J. Ayon
 Metabolites.2023; 13(5): 625.     CrossRef
- Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery
 Summaya Perveen, Rashmi Sharma
 Biochemical Pharmacology.2022; 197: 114906.     CrossRef
- Anti-tuberculosis treatment strategies and drug development: challenges and priorities
 Véronique A. Dartois, Eric J. Rubin
 Nature Reviews Microbiology.2022; 20(11): 685.     CrossRef
- Identification of small molecules targeting homoserine acetyl transferase from Mycobacterium tuberculosis and Staphylococcus aureus
 Deepika Chaudhary, Avantika Singh, Mardiana Marzuki, Abhirupa Ghosh, Saqib Kidwai, Tannu Priya Gosain, Kiran Chawla, Sonu Kumar Gupta, Nisheeth Agarwal, Sudipto Saha, Yashwant Kumar, Krishan Gopal Thakur, Amit Singhal, Ramandeep Singh
 Scientific Reports.2022;[Epub]     CrossRef
- In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
 Tanya Parish
 Expert Opinion on Drug Discovery.2020; 15(3): 349.     CrossRef
- The relevance of persisters in tuberculosis drug discovery
 Soma Mandal, Samuel Njikan, Anuradha Kumar, Julie V. Early, Tanya Parish
 Microbiology
.2019; 165(5): 492.     CrossRef
- Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products
 Carolina Rodrigues Felix, Rashmi Gupta, Sandra Geden, Jill Roberts, Priscilla Winder, Shirley A. Pomponi, Maria Cristina Diaz, John K. Reed, Amy E. Wright, Kyle H. Rohde
 Antimicrobial Agents and Chemotherapy.2017;[Epub]     CrossRef
- Targeting Phenotypically TolerantMycobacterium tuberculosis
 Ben Gold, Carl Nathan, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
 Microbiology Spectrum.2017;[Epub]     CrossRef
- Optimization and Evaluation of 5-Styryl-Oxathiazol-2-oneMycobacterium tuberculosisProteasome Inhibitors as Potential Antitubercular Agents
 Francesco Russo, Johan Gising, Linda Åkerbladh, Annette K. Roos, Agata Naworyta, Sherry L. Mowbray, Anders Sokolowski, Ian Henderson, Torey Alling, Mai A. Bailey, Megan Files, Tanya Parish, Anders Karlén, Mats Larhed
 ChemistryOpen.2015; 4(3): 342.     CrossRef